GENEMEDICS APP
GENEMEDICS NUTRITION
Author: Dr. George Shanlikian, M.D. | Last Updated: November 28th, 2024
Glycyrrhetinic acid benefits include its anti-inflammatory, antiviral, and antimicrobial properties, which make it effective in treating skin conditions, enhancing immune response, and promoting wound healing. Additionally, it has been shown to support liver health and provide relief from respiratory ailments.
Glycyrrhetinic acid, also known as glycyrrhizic acid, is one of the main bioactive compounds of licorice that is widely used in various foods as a natural sweetener. It’s also used to impart a flavor to a wide array of cosmetic and personal care products. As a therapeutic agent, glycyrrhetinic acid is also the main ingredient in various health formulations because of its anti-inflammatory, anti-ulcer, anti-allergic, anti-tumor, anti-diabetic, antioxidant, and liver-protective properties.
The medical use of glycyrrhetinic acid dates back to ancient Egyptian times when they used licorice root as a cure-all concoction. This herb also became an important treatment strategy in Chinese medicine. Interestingly, modern clinical trials found that the glycyrrhetinic acid in licorice exerts a potent therapeutic effect in a wide array of medical conditions.
Glycyrrhetinic acid is available in the alpha and beta forms. The alpha form is present in the highest amounts in the stomach and liver, and it is thought that the dominance of glycyrrhetinic acid in these areas can produce an anti-inflammatory effect. On the other hand, beta glycyrrhetinic acid exerts its beneficial effects by reducing lipid peroxidation and increasing antioxidant activity. Glycyrrhetinic acid also works to lower inflammatory substances and free radical levels in the body. Moreover, Glycyrrhetinic acid increases the levels of substances that stimulate gastric acid and mucus secretion in the digestive system.
Glycyrrhetinic acid may benefit people who are overweight or obese. Studies show that this powerful compound has the ability to promote fat loss:
There is also increasing evidence that supports the anti-diabetic effect of glycyrrhetinic acid:
Studies show that glycyrrhetinic acid also has immune-boosting properties that can help fight infection:
Numerous studies also show that glycyrrhetinic acid has potent anti-cancer properties:
Evidence suggests that glycyrrhetinic acid has a protective effect on liver injury through its anti-inflammatory activity:
Numerous studies suggest that the potent anti-inflammatory properties of glycyrrhetinic acid allow it to treat a multitude of inflammatory conditions:
Glycyrrhetinic acid side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on glycyrrhetinic acid. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of glycyrrhetinic acid. Despite this, it was listed as a side effect associated with glycyrrhetinic acid even though these associated side effects are very uncommon.
Side effects associated with glycyrrhetinic acid may include the following:
Glycyrrhetinic Acid cream is a topical treatment widely recognized for its potent anti-inflammatory properties. This makes it particularly effective for managing and alleviating symptoms associated with various skin conditions such as eczema, psoriasis, and dermatitis. By reducing inflammation and irritation, the cream helps soothe affected areas, providing relief from itching and discomfort commonly experienced with these conditions.
In addition to its anti-inflammatory benefits, Glycyrrhetinic Acid cream boasts strong antiviral and antimicrobial properties. These attributes make it a valuable tool in preventing and treating skin infections, enhancing the skin’s natural barrier against harmful pathogens. Its ability to promote wound healing further adds to its appeal, as it aids in the faster recovery of cuts, abrasions, and other minor skin injuries, reducing the risk of scarring and infection.
Moreover, Glycyrrhetinic Acid cream is noted for its gentle yet effective action, making it suitable for a variety of skin types, including sensitive skin. Its soothing properties not only calm irritated skin but also support the skin’s overall health and resilience. Regular use can improve skin texture and appearance, offering a practical and therapeutic option for those seeking to maintain healthy skin while addressing specific dermatological concerns.
Glycyrrhetinic Acid, derived from licorice root, is highly valued in dermatology for its potent anti-inflammatory properties. It effectively reduces redness, swelling, and irritation, making it an ideal ingredient for treating conditions such as eczema, psoriasis, and dermatitis. By inhibiting the enzymes that break down cortisol, Glycyrrhetinic Acid helps prolong the anti-inflammatory action, offering sustained relief from inflammatory skin issues.
Beyond its anti-inflammatory benefits, Glycyrrhetinic Acid exhibits strong antimicrobial and antiviral properties. These qualities make it useful in preventing and treating infections that can complicate skin conditions. It helps in controlling acne by reducing the proliferation of bacteria and calming inflamed skin, resulting in clearer and healthier skin. Additionally, its antiviral effects contribute to its effectiveness in treating viral-induced skin issues, such as cold sores.
Glycyrrhetinic Acid also plays a crucial role in skin repair and wound healing. It promotes the regeneration of skin cells and enhances the skin’s natural barrier function, which accelerates the healing process of minor cuts, burns, and other skin injuries. Furthermore, its soothing properties provide relief from itching and discomfort, contributing to overall skin health and comfort. By integrating Glycyrrhetinic Acid into skincare routines, individuals can achieve improved skin resilience and a more balanced complexion.
Glycyrrhetinic Acid is widely used in dermatological applications due to its potent anti-inflammatory and soothing properties. It is a common ingredient in topical creams and ointments designed to treat conditions such as eczema, psoriasis, and dermatitis. By reducing inflammation and irritation, Glycyrrhetinic Acid helps to alleviate the symptoms of these skin conditions, promoting healthier and clearer skin. Its ability to enhance skin repair processes also makes it valuable in formulations aimed at healing wounds and reducing the appearance of scars.
In addition to its dermatological uses, Glycyrrhetinic Acid is employed for its antiviral and antimicrobial benefits. It is often included in products intended to combat viral infections and bacterial overgrowth. This makes it particularly useful in treatments for conditions like cold sores, where its antiviral properties can help reduce the severity and duration of outbreaks. Furthermore, its antimicrobial action supports the body’s natural defenses, helping to prevent and manage infections more effectively.
Glycyrrhetinic Acid also plays a significant role in supporting liver health and respiratory function. It is utilized in supplements and medicinal formulations aimed at protecting the liver from damage and enhancing its detoxification capabilities. This can be particularly beneficial for individuals with liver conditions or those exposed to toxins. Additionally, Glycyrrhetinic Acid’s anti-inflammatory effects extend to the respiratory system, where it helps soothe inflamed mucous membranes, providing relief from conditions such as asthma and bronchitis. This versatile compound’s wide range of uses underscores its importance in both skincare and overall health maintenance.
Glycyrrhetinic Acid, derived from licorice root, is renowned for its potent anti-inflammatory properties, making it a valuable ingredient in skincare according to the code of federal regulations. It helps reduce redness and swelling associated with conditions like eczema, psoriasis, and rosacea by modulating the inflammatory response. By inhibiting the production of pro-inflammatory molecules, Glycyrrhetinic Acid soothes irritated skin and promotes a more even, calm complexion. The inflammatory response is a natural part of the body’s defense mechanism, but when it becomes chronic, it can lead to persistent skin issues. Glycyrrhetinic Acid helps manage the inflammatory response, ensuring that it does not exacerbate skin conditions as outlined in the code of federal regulations. Additionally, it supports the skin’s healing process by keeping the inflammatory response in check, thereby preventing further irritation and promoting healthier skin.
In addition to its anti-inflammatory benefits, Glycyrrhetinic Acid possesses strong antimicrobial properties by targeting inflammatory factors. This makes it effective in combating acne-causing bacteria, which are inflammatory factors, thereby reducing breakouts and preventing new ones from forming. Its ability to fight off harmful microbes, which can be inflammatory factors, also aids in maintaining a healthy skin barrier. This barrier is crucial for protecting against environmental stressors and infections, which are often driven by inflammatory factors, as stated in the code of federal regulations.
Furthermore, Glycyrrhetinic Acid is known for its skin-brightening effects. It inhibits tyrosinase, an enzyme involved in melanin production, which helps fade hyperpigmentation and dark spots by reducing reactive oxygen species generation. This leads to a more radiant and uniform skin tone. Additionally, reactive oxygen species generation is significantly decreased, contributing to Glycyrrhetinic Acid’s multifaceted benefits. These benefits make Glycyrrhetinic Acid a valuable addition to various skincare products aimed at improving skin health and appearance, particularly through its ability to manage reactive oxygen species generation. Overall, the reduction in reactive oxygen species generation by Glycyrrhetinic Acid enhances its effectiveness in promoting a healthy and vibrant complexion, in line with the code of federal regulations.
Licorice, scientifically known as Glycyrrhiza glabra, is a perennial herb native to parts of Europe and Asia. This plant is renowned for its sweet-tasting root, which has been utilized for centuries in both traditional and modern medicine. The sweetness of licorice root comes from glycyrrhizin, a compound significantly sweeter than sugar, which also contributes to its therapeutic properties. The World Health Organization recognizes licorice for its potential health benefits, particularly in digestive health. Studies supported by the World Health Organization suggest that licorice may have anti-inflammatory effects when used in moderation. In some cultures, licorice has been traditionally used to alleviate cough and sore throat symptoms. The potential health effects of licorice can be better understood through physiologically based pharmacokinetic modeling, which helps to predict the absorption, distribution, metabolism, and excretion of its compounds in the human body.
The medicinal uses of licorice are diverse, largely due to its anti-inflammatory, antiviral, and antimicrobial properties. It has been traditionally employed to treat ailments such as sore throats, digestive issues, and respiratory problems. Licorice is also used in modern pharmacology as a flavoring agent and to mask the taste of other medicinal ingredients. Furthermore, its extracts are found in various skincare products, owing to their soothing and healing effects on the skin. Licorice has also been studied for its potential to induce cell death in cancer cells, making it a subject of interest in oncological research. Its ability to induce cell death has sparked interest in its application in treating various forms of cancer. Additionally, licorice’s potential to induce cell death in cancer cells has prompted further investigation into its mechanisms and potential therapeutic applications in oncology. Researchers often use physiologically based pharmacokinetic modeling to explore these mechanisms and assess the effectiveness of licorice compounds in cancer treatment.
Beyond its medicinal applications, licorice is a popular flavoring in foods and beverages, particularly in candies and herbal teas. However, it is essential to consume licorice in moderation, as excessive intake can lead to side effects such as high blood pressure and potassium imbalances. This is due to the presence of glycyrrhizin, which can affect electrolyte balance in the body. Despite these potential risks, licorice remains a valuable plant in both culinary and medicinal contexts, prized for its distinctive flavor and wide-ranging health benefits. The effect of glycyrrhizin on electrolyte balance underscores the importance of moderation when enjoying licorice-based products. To ensure safe consumption, physiologically based pharmacokinetic modeling is utilized to predict how different dosages of licorice impact the human body, highlighting the need for balanced intake.
In summary, physiologically based pharmacokinetic modeling is a crucial tool in understanding the comprehensive effects of licorice on human health, aiding in the optimization of its therapeutic uses while minimizing potential risks.
Licorice extract, derived from the root of the Glycyrrhiza glabra plant, is widely celebrated for its beneficial effects on the skin. One of its primary components, Glycyrrhizin, possesses potent anti-inflammatory properties, making it highly effective in reducing redness, irritation, and swelling associated with conditions such as eczema, rosacea, and dermatitis. Glycyrrhizin also helps in regulating cytokines like IL-6, which play a crucial role in inflammatory responses. Additionally, licorice extract contains Licochalcone A, which helps to calm and soothe irritated skin, providing a more balanced and comfortable complexion. The effect of glycyrrhizin extends to enhancing skin health by mitigating inflammation through the inhibition of IL-6, thus contributing significantly to its therapeutic benefits.
Another significant advantage of licorice extract is its ability to lighten hyperpigmentation and even out skin tone. The extract inhibits the enzyme tyrosinase, which is responsible for the production of melanin. By reducing melanin production, licorice extract helps to diminish dark spots, sun damage, and post-inflammatory hyperpigmentation, resulting in a brighter and more uniform skin appearance. This makes it an excellent ingredient in products targeting age spots, melasma, and other forms of discoloration. Licorice extract achieves these effects by modulating the activity of nitric oxide synthase, which plays a crucial role in skin pigmentation regulation and is influenced by cytokines such as IL-6.
Furthermore, licorice extract offers antioxidant benefits that protect the skin from environmental stressors and free radical damage. These antioxidants help to maintain skin health by preventing premature aging and promoting skin cell regeneration. With its ability to address multiple skin concerns such as inflammation, pigmentation, and oxidative stress, licorice extract has become a popular and versatile ingredient in skincare formulations. By decreasing the expression of IL-6, licorice extract provides comprehensive care for a variety of skin types and issues.
Glycyrrhetinic Acid is a potent ingredient in skin care, renowned for its anti-inflammatory properties that make it highly effective in treating various skin conditions. It works by inhibiting enzymes that break down cortisol, thereby reducing inflammation and irritation. This makes it particularly useful for individuals with sensitive skin, eczema, and psoriasis, as it can help soothe redness, swelling, and discomfort. One mechanism through which Glycyrrhetinic Acid exerts its effects is by inhibiting hydroxysteroid dehydrogenase type enzymes, which are crucial in regulating cortisol levels in the skin. This inhibition leads to decreased inflammation and enhanced skin healing.
In addition to its anti-inflammatory benefits, Glycyrrhetinic Acid also possesses strong antimicrobial and antiviral properties. These characteristics make it a valuable addition to skin care products aimed at preventing and treating infections, including acne. By reducing bacterial growth on the skin, it helps maintain a clearer, healthier complexion. Moreover, its antioxidant properties contribute to protecting the skin from environmental stressors, further enhancing its role in comprehensive skincare routines. Glycyrrhetinic Acid is also known to modulate the activity of hydroxysteroid dehydrogenase type, making it particularly beneficial for skin health.
Beyond its soothing and protective capabilities, Glycyrrhetinic Acid also promotes wound healing and attenuates virulence gene expression skin regeneration. It aids in accelerating the repair process of attenuating virulence gene expression in damaged skin, making it beneficial for use in post-procedure treatments and products designed to attenuate virulence gene expression and heal minor cuts and abrasions. By supporting the skin’s natural healing mechanisms, Glycyrrhetinic Acid ensures a faster recovery and attenuates virulence gene expression helping maintain the skin’s integrity and appearance.
Glycyrrhetinic acid, a bioactive compound derived from licorice root, is widely recognized for its potent anti-inflammatory and antiviral properties. It is commonly used in traditional and modern medicine to treat conditions such as chronic hepatitis, where it helps reduce liver inflammation and improve liver function. Additionally, glycyrrhetinic acid has shown efficacy in managing respiratory infections and gastrointestinal disorders, making it a versatile component in various therapeutic applications.
In dermatology, glycyrrhetinic acid is often utilized for its soothing and healing effects on the skin. It is a key ingredient in many topical formulations aimed at treating conditions like eczema, psoriasis, and contact dermatitis due to its ability to reduce redness, swelling, and itching. Moreover, its antioxidant properties help protect the skin from oxidative stress and environmental damage, promoting overall skin health and vitality.
Beyond its medical uses, glycyrrhetinic acid is also employed in the cosmetic industry. It is included in formulations to lighten hyperpigmentation and improve skin tone, owing to its ability to inhibit the enzyme tyrosinase, which is involved in melanin production. This makes it a popular choice in products designed to treat dark spots, melasma, and uneven skin pigmentation, enhancing the appearance and uniformity of the skin.
Glycyrrhizin is a naturally occurring compound found in the root of the licorice plant (Glycyrrhiza glabra). It is a triterpenoid saponin glycoside responsible for the sweet taste of licorice root, which is often used in food, beverages, and traditional medicine. Glycyrrhizin has been used for centuries in various cultures for its medicinal properties and is known for its potential therapeutic effects.
In terms of medicinal benefits, glycyrrhizin is noted for its anti-inflammatory, antiviral, and hepatoprotective properties. It has been studied for its effectiveness in treating conditions such as chronic hepatitis, where it may help reduce liver inflammation and damage. Additionally, glycyrrhizin has shown promise in managing symptoms of respiratory infections and certain autoimmune diseases due to its ability to modulate the immune system.
However, excessive consumption of glycyrrhizin can lead to significant side effects, including hypertension, hypokalemia, and edema. These adverse effects are due to their influence on cortisol metabolism and mineralocorticoid activity, which can disrupt the balance of electrolytes and fluid in the body. Therefore, while glycyrrhizin has potential health benefits, it should be used with caution, especially in individuals with underlying health conditions or those taking medications that may interact with it.
Glycyrrhetinic acid is known for its pharmacological and biological activities, such as anti-inflammatory and soothing properties, making it beneficial for treating skin conditions such as eczema, psoriasis, and acne when used in topical applications. It helps to reduce redness and irritation, promotes healing, and can even out skin tone. However, its benefits extend beyond topical use; oral administration of glycyrrhetinic acid has also been explored for its potential systemic pharmacological and biological activities in managing various health conditions.
Yes, glycyrrhetinic acid is generally considered safe for topical use on the skin. It is well-tolerated by most people and is often used in skincare products for its anti-inflammatory and skin-soothing effects. Glycyrrhetinic acid achieves these benefits by inhibiting the enzyme 11β-hydroxysteroid dehydrogenase, which helps regulate cortisol levels and reduces inflammation in the skin. This mechanism makes it particularly effective in calming irritated skin and promoting overall skin health.
In moderate amounts, glycyrrhizic acid is safe to take orally. However, prolonged or excessive consumption can lead to side effects such as hypertension (high blood pressure), potassium loss, and potentially severe adverse effects in susceptible individuals. Glycyrrhizic acid inhibits the enzyme 11β-hydroxysteroid dehydrogenase, which regulates cortisol levels in the body. This inhibition can result in increased cortisol activity, contributing to the observed side effects. Therefore, monitoring intake is crucial to avoid these complications.
Glycyrrhetinic acid is a compound derived from glycyrrhizin, found in licorice root. It is valued for its anti-inflammatory, antioxidant, and skin-soothing properties. Glycyrrhetinic acid inhibits the enzyme 11β-hydroxysteroid dehydrogenase, which plays a crucial role in cortisol metabolism, thereby reducing inflammation and allergic reactions. This property makes it effective in treating conditions such as eczema and psoriasis. Understanding the mechanisms of action of glycyrrhetinic acid reveals its multifaceted benefits in dermatological applications.
Glycyrrhetinic acid is naturally found in licorice root (Glycyrrhiza glabra), which is used in traditional medicine and skincare formulations for its therapeutic benefits. The effects of glycyrrhizic acid include its anti-inflammatory and soothing properties, making it beneficial for treating skin conditions such as eczema, psoriasis, and acne. Glycyrrhetinic acid helps to reduce redness and irritation, promotes healing, and can even out skin tone. Incorporating licorice extract into skincare routines harnesses the effects of glycyrrhizic acid to calm irritated skin and enhance overall skin health.
Aminophylline glycyrrhetinic acid is sometimes used in topical creams for cellulite reduction. Research on its effectiveness is mixed, with some studies suggesting potential benefits in reducing fat deposits beneath the skin. The combination of aminophylline glycyrrhetinic acid targets cellulite by enhancing local circulation and promoting fat breakdown, which may be beneficial in managing metabolic syndrome-related conditions such as obesity and insulin resistance. However, further research is needed to fully understand its impact on metabolic syndrome and related health outcomes.
Aminophylline cream is sometimes used for reducing cellulite. While some users report positive effects, scientific evidence supporting its effectiveness in treating metabolic syndrome is limited and inconclusive. The mechanism of action of aminophylline cream in reducing cellulite remains unclear, and further research is needed to understand its potential mechanism of action in treating metabolic syndrome.
In skincare, glycyrrhetinic acid is used for its anti-inflammatory properties, which involve modulating the signaling pathway that triggers inflammation, helping to calm and soothe irritated skin. It can be found in creams, serums, and lotions targeting sensitive or inflamed skin conditions, where it acts through this signaling pathway to reduce redness and promote skin healing.
In skincare formulations, glycyrrhetinic acid serves as a potent anti-inflammatory agent, effectively reducing inflammation, redness, and irritation on the skin. Its antioxidant properties further enhance its ability to soothe the skin. The modulation of pathways such as PI3K AKT signaling contributes significantly to its therapeutic effects, making glycyrrhetinic acid an excellent choice for addressing inflammatory skin conditions. Therefore, formulations containing glycyrrhetinic acid are beneficial for promoting skin healing and alleviating discomfort associated with various skin issues.
Glycyrrhizic acid can be toxic in high doses, leading to adverse effects such as hypertension, potassium loss, and potentially severe health issues. Excessive consumption of glycyrrhizic acid has been associated with elevated blood pressure and electrolyte imbalances due to its ability to inhibit pi3k akt. Therefore, it is important to consume licorice products containing glycyrrhizic acid in moderation.
When used appropriately, glycyrrhetinic acid is considered safe. However, excessive or prolonged use can potentially lead to adverse effects, particularly in sensitive individuals. It’s important to monitor the duration and dosage of glycyrrhetinic acid to mitigate any risks associated with its use, including acute liver injury induced by improper use. Chinese herbal medicine has long emphasized such monitoring to ensure safety and efficacy. In the realm of medicine, researchers are exploring a plant-derived thrombin inhibitor that may offer new therapeutic opportunities. Acute liver injury induced by certain medications is a critical area of concern, making the monitoring of herbal compounds even more crucial. Understanding the mechanisms behind acute liver injury induced by these substances can lead to better prevention and treatment strategies.
Foods that contain glycyrrhizin, such as licorice candies, herbal teas made from licorice root, and some traditional Chinese herbal medicines, are known for their various health benefits. Glycyrrhizin has been studied for its potential effects on inflammation and immune function, making it a valuable component in natural remedies. When considering dietary choices to support health, options like licorice candies, herbal teas made from licorice root, and traditional Chinese herbal medicines containing glycyrrhizin may offer beneficial effects on inflammation and immune function.
Side effects of glycyrrhizin include hypertension, hypokalemia (low potassium levels), edema (swelling), and in severe cases, cardiac arrhythmias or even renal failure. Glycyrrhizin can potentially interact with various physiological pathways, such as PI3K AKT signaling, exacerbating these effects if consumed in excess. Therefore, monitoring PI3K AKT activity is crucial when considering glycyrrhizin consumption to mitigate these risks. Glycyrrhizin’s influence on PI3K AKT signaling underscores the importance of understanding its impact on transcription factor regulation, which can further inform clinical strategies for managing associated adverse effects.
The main dangers of glycyrrhizic acid stem from its potential to cause hypertension and potassium loss, especially with long-term or high-dose consumption. This compound’s anti-inflammatory activity can be beneficial in certain contexts, but its effects on blood pressure and electrolyte balance must be carefully monitored to avoid adverse health outcomes related to its half life transcription factor anti-inflammatory activity.
Licorice consumption poses significant risks due to glycyrrhizic acid, which can cause adverse effects such as acute liver injury, hypertension, hypokalemia, and edema. These effects highlight the importance of monitoring licorice intake to safeguard intestinal bacteria and overall health. Excessive consumption of licorice may disrupt the balance of intestinal bacteria, emphasizing the need for moderation in its use to prevent harmful impacts on health, particularly concerning half-life acute liver injury.
Glycyrrhizin has several potential benefits, including anti-inflammatory, antioxidant, and antimicrobial properties. Glycyrrhetinic acid induces is used in traditional medicine for its therapeutic effects on various health conditions, influencing signaling pathways that regulate inflammation and immune responses. Glycyrrhetinic acid is particularly noted for its ability to modulate inflammatory processes, contributing to its efficacy in treating inflammatory diseases. It also plays a role in enhancing antioxidant defenses within cells. Glycyrrhetinic acid influences signaling pathways that regulate inflammation and immune responses, making it a versatile compound in therapeutic applications.
Glycyrrhizic acid and 18β can be harmful due to their potential to disrupt signaling pathways, causing hypertension and potassium loss, which can lead to serious health complications if not monitored. Li x Chronic hepatitis Glycyrrhizic acid and 18β should be used cautiously to avoid these risks. Li x Chronic hepatitis.
Yes, licorice extract can be applied topically to the skin. It is often used in skincare products for its soothing and anti-inflammatory properties. Licorice extract contains active compounds that modulate signaling pathways involved in inflammation and skin repair, making it effective for calming irritated skin and promoting healing. These signaling pathways help regulate cellular responses to stress and injury, supporting overall skin health and resilience. Therefore, licorice extract is a popular choice in skincare formulations aiming to leverage glucocorticoid receptor activation for improved skin condition and appearance.
Licorice extract is known for its skin-lightening properties, helping to fade dark spots and hyperpigmentation over time with regular use. This effect is attributed to its ability to inhibit melanin production through interference with the melanogenesis signaling pathway in the skin cells. Additionally, licorice extract can support the immune system by providing anti-inflammatory benefits. Licorice extract also exhibits anti-inflammatory properties, which can help reduce redness and irritation by calming inflammatory cells in the skin, thereby supporting the immune system. This makes it a versatile ingredient in skincare products targeting various skin concerns. Moreover, the immune system can benefit from the anti-inflammatory properties of licorice extract, which helps in reducing inflammation. Using licorice extract in skincare can, therefore, have an indirect positive effect on the immune system by reducing skin inflammation and irritation.
Yes, licorice extract can brighten skin tone by modulating pigmentation through its influence on the melanin signaling pathway, ultimately promoting a more even complexion. Licorice extract has been studied for its effects on various cell lines involved in melanin production, suggesting its potential to inhibit melanin synthesis and reduce hyperpigmentation, resulting in fewer adverse effects compared to harsher chemical treatments. This makes it a promising ingredient in skincare products targeting uneven skin tone due to its efficacy and fewer adverse effects. Additionally, licorice extract’s natural origin can lead to fewer adverse effects, making it a safer choice for those with sensitive skin.
Licorice extract can be used topically in various forms such as creams, serums, or masks to alleviate skin issues. Glycyrrhizic acid, evaluated in dose-dependent studies, is applied directly to cleansed skin, focusing on areas of concern or overall facial application, to mitigate the lipopolysaccharide induced inflammatory response. Glycyrrhizic acid, evaluated in dose-dependent studies, Glycyrrhizic acid, evaluated in dose-dependent studies, Glycyrrhizic acid evaluated.
Stearyl Glycyrrhetinate, a derivative of glycyrrhetinic acid, is generally considered safe for topical use in skincare products. It is valued for its anti-inflammatory and skin-soothing effects. Stearyl Glycyrrhetinate is typically used at concentrations ranging from 0.1 mg kg to 5 mg kg in cosmetic formulations, ensuring efficacy while maintaining safety. Its ability to calm and moisturize the skin makes it a popular ingredient in products designed for sensitive skin. Research supports its efficacy in reducing redness and irritation, with studies demonstrating positive results at concentrations as low as 0.5 mg kg. Overall, Stearyl Glycyrrhetinate at recommended doses offers a gentle yet effective option for enhancing skin health and appearance.
Glycyrrhizic acid can be safe when used appropriately, but excessive consumption or prolonged use can lead to adverse effects such as hypertension and potassium loss (Wang H). These effects are partly attributed to glycyrrhizic acid’s ability to inhibit nuclear factor κB, a key regulator of inflammatory cytokines and immune response (Wang H). Therefore, while nuclear factor inhibition can offer therapeutic benefits by reducing inflammatory cytokines, it underscores the importance of moderation in consuming glycyrrhizic acid to avoid potential health risks, including those associated with inflammatory cytokines (Wang H).
Glycyrrhetinic acid and 18β glycyrrhetinic (100 mg) are used in skincare for their anti-inflammatory, antioxidant, and soothing properties, making them effective in calming irritated skin, reducing redness, and promoting overall skin health. Beyond skincare, research suggests glycyrrhetinic acid and 18β glycyrrhetinic (100 mg) may also benefit liver diseases due to their potential hepatoprotective effects, aiding in liver health and function. For optimal results, a daily dose of 100 mg is recommended.
Glycyrrhizin can be safe when consumed in moderation or used in skincare products as directed. However, caution is advised due to its potential to cause adverse effects in high doses, especially because glycyrrhizin can interact with the glucocorticoid receptor. It’s recommended to adhere to dosage guidelines to avoid exceeding safe intake levels, typically around 2 mg kg body weight per day in oral consumption. When applying glycyrrhizin topically, ensure concentrations are within safe limits, typically less than 1 mg kg body weight per application to prevent skin irritation or sensitization. Monitoring glycyrrhizin intake is crucial since excessive amounts can lead to significant interactions with the glucocorticoid receptor, which may result in undesirable health effects. By following these guidelines, one can minimize the risk of adverse reactions related to glucocorticoid receptor interactions.
Foods that contain glycyrrhizin include licorice candies, certain herbal teas made from licorice root extract, and some traditional Chinese herbal medicines. Glycyrrhizin is a natural compound found in licorice root (Glycyrrhiza glabra), and it is extracted to produce various forms, including 18β glycyrrhetinic acid used in both traditional medicine and modern applications. Wang W states that glycyrrhizin is prevalent in these foods. Wang W’s research highlights the use of glycyrrhizin in modern applications. According to Wang W, traditional Chinese herbal medicines often utilize glycyrrhizin.
Glycyrrhizin is a natural compound found in licorice root (Glycyrrhiza glabra). Licorice root extract containing glycyrrhizin is extracted and used in various forms in both traditional medicine and modern applications. In traditional Chinese medicine, glycyrrhizin has been utilized for centuries to treat various ailments, including liver diseases. Today, research continues to explore its potential benefits in managing liver diseases and improving overall liver health. Nitric oxide plays a significant role in this context, as glycyrrhizin’s interaction with nitric oxide pathways may contribute to its therapeutic effects. As a versatile ingredient, glycyrrhizin’s presence in skincare and medicinal products underscores its broad spectrum of therapeutic applications, beyond its historical use in liver diseases. Additionally, the modulation of nitric oxide by glycyrrhizin can influence various physiological processes, highlighting the importance of nitric oxide in understanding the mechanism of action of glycyrrhizin, which is crucial for maximizing its therapeutic potential.
Moon MH, Jeong JK, Lee YJ, et al. 18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis. BiochemBiophys Res Commun. 2012;420(4):805-10.
18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis
The study by Moon MH et al. investigated the effects of 18β-Glycyrrhetinic acid on adipogenic differentiation and lipolysis. Their research demonstrated that this compound inhibits the process of adipogenic differentiation (the formation of fat cells) and stimulates lipolysis (the breakdown of fats). These findings suggest that 18β-Glycyrrhetinic acid may have potential applications in controlling fat accumulation and metabolism
Know more about this study https://www.sciencedirect.com/science/article/pii/S0006291X12005384
Armanini D, De palo CB, Mattarello MJ, et al. Effect of licorice on the reduction of body fat mass in healthy subjects. J Endocrinol Invest. 2003;26(7):646-50.
Effect of licorice on the reduction of body fat mass in healthy subjects
The study by Armanini et al. investigated the effect of licorice on the reduction of body fat mass in healthy subjects. Their research aimed to understand whether licorice consumption had an impact on body fat mass. The study’s findings suggest that licorice may contribute to a reduction in body fat mass in healthy individuals.
Know more about this study https://link.springer.com/article/10.1007/BF03347023
Armanini D, Nacamulli D, Francini-pesenti F, Battagin G, Ragazzi E, Fiore C. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids. 2005;70(8):538-42.
Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application
The study by Armanini et al. investigated the effects of glycyrrhetinic acid, the active principle of licorice, when applied topically on the reduction of subcutaneous thigh fat thickness. Their research found that topical application of glycyrrhetinic acid reduced the thickness of subcutaneous thigh fat. This suggests a potential use for glycyrrhetinic acid in localized fat reduction.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0039128X05000577
Park M, Lee JH, Choi JK, et al. 18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity. MolNutr Food Res. 2014;58(7):1436-46.
18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity
The study by Park et al. investigated the effects of 18β-glycyrrhetinic acid on anandamide-induced adiposity and high-fat diet-induced obesity. Their research demonstrated that this compound attenuated adiposity induced by anandamide and obesity resulting from a high-fat diet. This suggests that 18β-glycyrrhetinic acid may have potential as a therapeutic agent for managing adiposity and obesity.
Know more about this study https://onlinelibrary.wiley.com/doi/abs/10.1002/mnfr.201300763
Kamisoyama H, Honda K, Tominaga Y, Yokota S, Hasegawa S. Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats. BiosciBiotechnolBiochem. 2008;72(12):3225-31.
Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats
The study by Kamisoyama et al. investigated the anti-obesity action of licorice flavonoid oil in diet-induced obese rats. Their research aimed to understand the potential anti-obesity effects of licorice flavonoid oil. The study’s findings suggest that licorice flavonoid oil may have anti-obesity properties, as it was tested in diet-induced obese rats.
Know more about this study https://www.tandfonline.com/doi/abs/10.1271/bbb.80469
Honda K, Kamisoyama H, Tominaga Y, Yokota S, Hasegawa S. The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats. AnimSci J. 2009;80(5):562-9.
The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats
The study by Honda et al. aimed to uncover the molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high-fat diet-induced obese rats. Their research delved into the molecular processes and mechanisms that contribute to the reduction in abdominal fat accumulation observed when using licorice flavonoid oil. These findings provide insights into the potential molecular targets involved in the anti-obesity effects of this compound.
Know more about this study https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1740-0929.2009.00670.x
Tominaga Y, Nakagawa K, Mae T, et al. Licorice flavonoid oil reduces total body fat and visceral fat in overweight subjects: A randomized, double-blind, placebo-controlled study. Obes Res ClinPract. 2009;3(3):I-IV.
Licorice flavonoid oil reduces total body fat and visceral fat in overweight subjects: A randomized, double-blind, placebo-controlled study
The study by Tominaga et al. conducted a randomized, double-blind, placebo-controlled study to investigate the effects of licorice flavonoid oil on total body fat and visceral fat in overweight subjects. Their research found that licorice flavonoid oil supplementation resulted in a reduction in total body fat and visceral fat in overweight individuals. This suggests that licorice flavonoid oil may have potential benefits for weight management.
Know more about this study https://www.sciencedirect.com/science/article/pii/S1871403X09000350
Ko BS, Jang JS, Hong SM, et al. Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw GlycyrrhizauralensisFisch, modify insulin sensitizing and insulinotropic actions. BiosciBiotechnolBiochem. 2007;71(6):1452-61.
Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw GlycyrrhizauralensisFisch, modify insulin sensitizing and insulinotropic actions
The study by Ko et al. investigated changes in components, specifically glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch and their impact on insulin sensitizing and insulinotropic actions. Their research explored how variations in these components within the plant can modify the effects on insulin sensitivity and insulin secretion. These findings contribute to our understanding of the potential mechanisms underlying the actions of Glycyrrhiza uralensis Fisch on glucose metabolism.
Know more about this study https://www.jstage.jst.go.jp/article/bbb/71/6/71_60533/_article/-char/ja/
Kalaiarasi P, Kaviarasan K, Pugalendi KV. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats. Eur J Pharmacol. 2009;612(1-3):93-7.
Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats
The study by Kalaiarasi et al. investigated the hypolipidemic (cholesterol-lowering) activity of 18β-glycyrrhetinic acid in streptozotocin-induced diabetic rats. Their research aimed to understand the potential benefits of 18β-glycyrrhetinic acid in reducing lipid levels in diabetic rats. The study’s findings suggest that this compound may have a hypolipidemic effect, which can be beneficial in managing lipid abnormalities associated with diabetes.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0014299909003343
Hou S, Zheng F, Li Y, Gao L, Zhang J. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose. Int J Mol Sci. 2014;15(9):15026–15043. Published 2014 Aug 26. doi:10.3390/ijms150915026
The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose
The study by Hou et al. investigated the protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose. Their research focused on assessing how glycyrrhizic acid can protect renal tubular epithelial cells from injury caused by elevated glucose levels. The study’s findings provide insights into the potential therapeutic applications of glycyrrhizic acid in preventing kidney cell damage associated with high glucose levels.
Know more about this study https://www.mdpi.com/1422-0067/15/9/15026
Takii H, Kometani T, Nishimura T, Nakae T, Okada S, Fushiki T. Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice. Biol Pharm Bull. 2001;24(5):484-7.
Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice
The study by Takii et al. investigated the antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice. Their research aimed to understand the potential benefits of glycyrrhizin in managing diabetes in these genetically diabetic mice. The study’s findings suggest that glycyrrhizin may have an antidiabetic effect in KK-Ay mice, which provides insights into its potential as a treatment for diabetes.
Know more about this study https://www.jstage.jst.go.jp/article/bpb/24/5/24_5_484/_article/-char/ja/
Sen S, Roy M, Chakraborti AS. Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J Pharm Pharmacol. 2011;63(2):287-96.
Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats
The study by Sen et al. investigated the ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. Their research aimed to assess how glycyrrhizin could alleviate the effects of diabetes induced by streptozotocin in rats. The study’s findings suggest that glycyrrhizin may have beneficial effects in improving the condition of diabetic rats.
Know more about this study https://academic.oup.com/jpp/article-abstract/63/2/287/6135488
Li JY, Cao HY, Liu P, Cheng GH, Sun MY. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014:872139.
Glycyrrhizic acid in the treatment of liver diseases: literature review
The literature review conducted by Li et al. focuses on the use of glycyrrhizic acid in the treatment of liver diseases. Their research provides an overview of the existing literature related to the potential therapeutic effects of glycyrrhizic acid in various liver diseases. This review may offer valuable insights into the applications of glycyrrhizic acid as a treatment for liver-related conditions.
Know more about this study https://www.hindawi.com/journals/bmri/2014/872139/abs/
Pompei R, Flore O, Marccialis MA. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 1979;281(5733):689–690.
Glycyrrhizic acid inhibits virus growth and inactivates virus particles
The study by Pompei et al. discovered that glycyrrhizic acid has the ability to inhibit virus growth and inactivate virus particles. Their research, published in the journal Nature in 1979, demonstrated the antiviral properties of glycyrrhizic acid, which can be significant in the context of controlling viral infections. This discovery highlights the potential antiviral applications of glycyrrhizic acid.
Know more about this study https://www.nature.com/articles/281689a0
Michaelis M, Geiler J, Naczk P, et al. Glycyrrhizin exerts antioxidativeeffects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS ONE. 2011;6(5)e19705.
Glycyrrhizin exerts antioxidativeeffects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression
The study by Michaelis et al. investigated the effects of glycyrrhizin in H5N1 influenza A virus-infected cells. Their research demonstrated that glycyrrhizin exerts antioxidative effects, inhibits virus replication, and reduces pro-inflammatory gene expression in cells infected with H5N1 influenza A virus. These findings suggest that glycyrrhizin may have potential antiviral and anti-inflammatory properties, which can be valuable in the context of influenza infections.
Know more about this study https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0019705
Ming LJ, Yin AC. Therapeutic effects of glycyrrhizic acid. Nat Prod Commun. 2013;8(3):415-8.
Therapeutic effects of glycyrrhizic acid
The review article by Ming and Yin discusses the therapeutic effects of glycyrrhizic acid. It provides insights into the various potential therapeutic applications of glycyrrhizic acid, including its anti-inflammatory, antiviral, and antioxidant properties. This review article serves as a valuable resource for understanding the diverse therapeutic benefits of glycyrrhizic acid.
Know more about this study https://journals.sagepub.com/doi/abs/10.1177/1934578X1300800335
Long DR, Mead J, Hendricks JM, Hardy ME, Voyich JM. 18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression. Antimicrob Agents Chemother. 2013;57(1):241–247. doi:10.1128/AAC.01023-12.
18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression
The study by Long et al. investigated the effects of 18β-glycyrrhetinic acid on methicillin-resistant Staphylococcus aureus (MRSA). Their research demonstrated that this compound inhibits the survival of MRSA and reduces the expression of virulence genes in the bacteria. This suggests that 18β-glycyrrhetinic acid may have potential as an antimicrobial agent against MRSA and could help attenuate its virulence.
Know more about this study https://journals.asm.org/doi/abs/10.1128/aac.01023-12
Oyama K, Kawada-Matsuo M, Oogai Y, Hayashi T, Nakamura N, Komatsuzawa H. Antibacterial Effects of Glycyrrhetinic Acid and Its Derivatives on Staphylococcus aureus. PLoS One. 2016;11(11):e0165831. Published 2016 Nov 7. doi:10.1371/journal.pone.0165831
Antibacterial Effects of Glycyrrhetinic Acid and Its Derivatives on Staphylococcus aureus
The study by Oyama et al. investigated the antibacterial effects of glycyrrhetinic acid and its derivatives on Staphylococcus aureus. Their research demonstrated the potential of glycyrrhetinic acid and its derivatives in inhibiting the growth of Staphylococcus aureus, a pathogenic bacterium. This suggests that these compounds may have antibacterial properties that can be valuable in combating Staphylococcus aureus infections.
Know more about this study https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165831
Cao D, Jiang J, You L, et al. The Protective Effects of 18β-Glycyrrhetinic Acid on Helicobacter pylori-Infected Gastric Mucosa in Mongolian Gerbils. Biomed Res Int. 2016;2016:4943793. doi:10.1155/2016/4943793
The Protective Effects of 18β-Glycyrrhetinic Acid on Helicobacter pylori-Infected Gastric Mucosa in Mongolian Gerbils.
The study by Cao et al. investigated the protective effects of 18β-glycyrrhetinic acid on Helicobacter pylori-infected gastric mucosa in Mongolian gerbils. Their research aimed to understand how this compound could protect the gastric mucosa from the damaging effects of Helicobacter pylori infection. The findings suggest that 18β-glycyrrhetinic acid may have a protective role in mitigating the impact of Helicobacter pylori infection on the gastric mucosa.
Know more about this study https://www.hindawi.com/journals/bmri/2016/4943793/abs/
Matsumoto Y, Matsuura T, Aoyagi H, Matsuda M, Hmwe SS, Date T, et al. (2013) Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro. PLoS ONE 8(7): e68992. https://doi.org/10.1371/journal.pone.0068992.
Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
The study by Matsumoto et al. investigated the antiviral activity of glycyrrhizin against Hepatitis C Virus (HCV) in vitro. Their research demonstrated that glycyrrhizin exhibits antiviral effects against HCV, making it a potential candidate for the treatment of HCV infections. This finding highlights the therapeutic potential of glycyrrhizin in combating HCV.
Know more about this study https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068992
Ikeda K. Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C. Hepatology Research. 2007;37(2):S287–S293.
Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C
The study by Ikeda investigated the use of glycyrrhizin injection therapy in preventing hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C. The research suggested that glycyrrhizin injection therapy may be effective in reducing the risk of hepatocellular carcinoma in patients with chronic hepatitis C who do not respond to interferon treatment. This highlights the potential therapeutic role of glycyrrhizin in managing liver-related complications in hepatitis C patients.
Know more about this study https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1872-034X.2007.00199.x
Wang H-F, Su H-B, Liu H-L, et al. Clinical research on treatment on several kinds of liver hepatitis with diammoniumglycyrrhizinate. Chinese Journal of Infectious Diseases. 2004;22(2):113–115.
Clinical research on treatment on several kinds of liver hepatitis with diammoniumglycyrrhizinate
The clinical research conducted by Wang et al. focused on the treatment of several types of liver hepatitis using diammonium glycyrrhizinate. The study aimed to evaluate the efficacy of diammonium glycyrrhizinate in treating various forms of liver hepatitis. Their findings may provide insights into the potential therapeutic benefits of this compound in managing hepatitis-related liver conditions.
Know more about this study https://pesquisa.bvsalud.org/portal/resource/pt/wpr-554913
asui S, Fujiwara K, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis. Dig Dis Sci. 2011;56(12):3638-47.
Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis
The study by Yasui et al. assessed the efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis. Their research aimed to determine whether intravenous administration of glycyrrhizin could be effective in treating patients with acute autoimmune hepatitis. The findings suggested potential benefits of glycyrrhizin in managing this condition during its early stages.
Know more about this study https://link.springer.com/article/10.1007/s10620-011-1789-5
Cao Y, Tang X-Y, Song F-W. Compare of and beta-Glycyrrhetinic acid alpha-Glycyrrhetinic acid in the treatment of Chronic Hepatitis B. China Journal of Modern Medicine. 2002;12(7):91–92.
Compare of and beta-Glycyrrhetinic acid alpha-Glycyrrhetinic acid in the treatment of Chronic Hepatitis B
The study by Cao et al. aimed to compare the effectiveness of alpha-glycyrrhetinic acid and beta-glycyrrhetinic acid in the treatment of Chronic Hepatitis B. Their research sought to evaluate the therapeutic potential of these two compounds for managing this type of hepatitis. The findings may provide insights into the relative efficacy of alpha-glycyrrhetinic acid and beta-glycyrrhetinic acid in the context of Chronic Hepatitis B treatment.
Available from https://academic.oup.com/jac/article/67/8/1905/748574.
Available from https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-9-96.
Steinstraesser L, Schubert C, Jacobsen F, Al-benna S. Editorial: glycyrrhizin against multi-resistant bacteria?. J Leukoc Biol. 2010;87(1):7-8.
Glycyrrhizin against multi-resistant bacteria?
The editorial by Steinstraesser et al. titled “Glycyrrhizin against multi-resistant bacteria?” discusses the potential use of glycyrrhizin in combating multi-resistant bacteria. The authors likely explore the antimicrobial properties of glycyrrhizin and its potential as a therapeutic agent against bacteria that have developed resistance to conventional antibiotics. This editorial provides insights into the ongoing research and interest in glycyrrhizin as a possible solution to antibiotic-resistant bacterial infections.
Know more about this study https://academic.oup.com/jleukbio/article-abstract/87/1/7/6959788
Utsunomiya T, Kobayashi M, Ito M, Pollard RB, Suzuki F. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses. Clinical Immunology. 2000;95(2):145–155.
Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses
The study conducted by Utsunomiya et al. investigated the effects of glycyrrhizin on MAIDS (Murine AIDS) mice and their resistance to opportunistic infections caused by Candida albicans. The research focused on how glycyrrhizin modulates the type 2 T cell responses associated with MAIDS, potentially enhancing the immune system’s ability to combat Candida albicans infections in these mice. The findings of this study suggest that glycyrrhizin may have immunomodulatory properties that can improve the host’s resistance to opportunistic infections.
Know more about this study https://www.sciencedirect.com/science/article/pii/S152166160094854X
Roohbakhsh A, Iranshahy M, Iranshahi M. Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship. Curr Med Chem. 2016;23(5):498-517.
Glycyrrhetinic acid and its derivatives: anti-cancer and cancer chemopreventive properties, mechanisms of action and structure-cytotoxic activity relationship
The study by Roohbakhsh et al. provides insights into the anti-cancer and cancer chemopreventive properties of glycyrrhetinic acid and its derivatives. It delves into the mechanisms of action and the structure-cytotoxic activity relationship of these compounds. The research highlights the potential of glycyrrhetinic acid and its derivatives as promising agents for cancer treatment and prevention.
Know more about this study https://www.ingentaconnect.com/content/ben/cmc/2016/00000023/00000005/art00007
Cai Y, Zhao B, Liang Q, Zhang Y, Cai J, Li G. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells. Eur J Pharmacol. 2017;809:87-97.
The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells
The study by Cai et al. investigates the selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis when combined with etoposide in triple-negative breast cancer MDA-MB-231 cells. Their research explores the potential of these compounds to enhance the effects of etoposide in treating this type of breast cancer.
Know more about this study https://www.sciencedirect.com/science/article/pii/S001429991730345X
Rossi T, Benassi L, Magnoni C, Ruberto AI, Coppi A, Baggio G. Effects of glycyrrhizin on UVB-irradiated melanoma cells. In Vivo. 2005;19(1):319-22.
Effects of glycyrrhizin on UVB-irradiated melanoma cells
In the study conducted by Rossi et al., the researchers investigated the impact of glycyrrhizin on melanoma cells exposed to UVB radiation, a known factor in skin cancer development. The research aimed to determine whether glycyrrhizin could exert protective effects against UVB-induced damage in melanoma cells. Their findings suggest that glycyrrhizin may have a beneficial effect in mitigating the harmful consequences of UVB radiation on these cells. This study contributes valuable insights into the potential utility of glycyrrhizin in the context of skin cancer prevention and treatment, offering a promising avenue for further research in this area.
Know more about this study https://iv.iiarjournals.org/content/19/1/319.short
Wang S, Shen Y, Qiu R, Chen Z, Chen Z, Chen W. 18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration. Int J Oncol. 2017;51(2):615-624.
18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration
The study by Wang et al. investigated the anticancer properties of 18β-glycyrrhetinic acid (18β-GA) against colorectal cancer. Their research focused on evaluating the impact of 18β-GA on colorectal cancer cells, particularly its effects on cell proliferation and migration. The findings of this study revealed that 18β-GA exhibited potent antitumor effects by significantly inhibiting both cell proliferation and migration in colorectal cancer cells. These results highlight the potential therapeutic value of 18β-GA in the treatment of colorectal cancer, offering a promising avenue for further research into its mechanisms of action and clinical applications.
Know more about this study https://www.spandidos-publications.com/10.3892/ijo.2017.4059
Alho DPS, Salvador JAR, Cascante M, Marin S. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives. Molecules. 2019;24(4).
Synthesis and antiproliferative activity of novel heterocyclic glycyrrhetinic acid derivatives
In their study, Alho et al. synthesized novel heterocyclic derivatives of glycyrrhetinic acid and evaluated their antiproliferative activity. The research aimed to discover new compounds with potential anticancer properties. These synthesized derivatives were assessed for their ability to inhibit cell proliferation. The study found that some of the novel compounds exhibited promising antiproliferative activity, suggesting their potential as candidates for further development in the field of cancer therapeutics. This research contributes to the exploration of innovative compounds derived from glycyrrhetinic acid for their potential use in combating cancer.
Know more about this study https://www.mdpi.com/1420-3049/24/4/766
Cai H, Chen X, Zhang J, Wang J. 18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway. J Nat Med. 2018;72(1):252-259.
18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway
In their study, Cai et al. investigated the potential anticancer properties of 18β-glycyrrhetinic acid (GA) on human gastric cancer cells. The research focused on understanding the mechanisms underlying GA’s effects on cancer cell migration and invasion. The study revealed that GA inhibited the migration and invasion of gastric cancer cells through the regulation of the ROS/PKC-α/ERK pathway. These findings suggest that GA may have therapeutic potential in suppressing the metastatic properties of gastric cancer by targeting specific signaling pathways. This research contributes to the exploration of natural compounds like GA as potential agents for cancer treatment and highlights the importance of understanding their mechanisms of action.
Know more about this study https://link.springer.com/article/10.1007/s11418-017-1145-y
Chintharlapalli S, Papineni S, Jutooru I, Mcalees A, Safe S. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells. Mol Cancer Ther. 2007;6(5):1588-98.
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
Chintharlapalli et al. conducted a study to investigate the structure-dependent activity of glycyrrhetinic acid (GA) derivatives as peroxisome proliferator-activated receptor gamma (PPARγ) agonists in colon cancer cells. The research focused on understanding how different structural modifications of GA influenced their ability to activate PPARγ, a nuclear receptor with potential implications in cancer therapy. The study found that specific derivatives of GA demonstrated PPARγ agonist activity in colon cancer cells. These findings suggest that GA derivatives have the potential to modulate PPARγ and may be considered for further development as agents for colon cancer treatment. This research sheds light on the structural aspects that influence GA’s activity in cancer cells.
Know more about this study https://aacrjournals.org/mct/article-abstract/6/5/1588/234986
Tang ZH, Li T, Chang LL, et al. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem. 2014;62(49):11910-6.
Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells
In a study by Tang et al., glycyrrhetinic acid (GA) was investigated for its effects on hepatocellular carcinoma (HCC) cells. The research focused on how GA triggered a protective autophagy response in HCC cells through the activation of extracellular regulated protein kinases (ERKs). Autophagy is a cellular process that can have both protective and detrimental effects, and it plays a role in cancer cell survival. The study found that GA induced autophagy in HCC cells by activating ERKs, which suggests that GA may have a potential role in modulating autophagy as a protective mechanism in HCC treatment. This research provides insights into the molecular mechanisms of GA in cancer cells.
Know more about this study https://pubs.acs.org/doi/abs/10.1021/jf503968k
Chang M, Wu M, Li H. Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway. Am J Transl Res. 2017;9(12):5567–5575. Published 2017 Dec 15.
Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway
In a study conducted by Chang et al., the combination of curcumin and glycyrrhetinic acid (GA) was investigated for its inhibitory effects on the development of hepatocellular carcinoma (HCC) cells. The study focused on the PTEN/PI3K/AKT signaling pathway, which is known to play a crucial role in cancer progression. The results showed that the combination of curcumin and GA led to the down-regulation of this signaling pathway in HCC cells. This inhibition of the PTEN/PI3K/AKT pathway contributed to the suppression of HCC cell development. The study suggests that the combination of curcumin and GA may have potential therapeutic benefits for HCC by targeting key signaling pathways involved in cancer growth.
Know more about this study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752906/
Chen G, Li J, Cai Y, et al. A Glycyrrhetinic Acid-Modified CurcuminSupramolecular Hydrogel for liver tumor targeting therapy. Sci Rep. 2017;7:44210. Published 2017 Mar 10.
A Glycyrrhetinic Acid-Modified CurcuminSupramolecular Hydrogel for liver tumor targeting therapy
Chen et al. developed a novel approach for liver tumor targeting therapy by creating a supramolecular hydrogel modified with glycyrrhetinic acid (GA) and loaded with curcumin. This innovative formulation aimed to improve the delivery of curcumin to liver tumors. Glycyrrhetinic acid is known to have an affinity for liver cells.
The study demonstrated that the GA-modified curcumin supramolecular hydrogel exhibited effective liver tumor targeting capabilities. It provided a controlled and sustained release of curcumin specifically to liver tumor sites, enhancing its therapeutic potential. This approach holds promise for the treatment of liver tumors by utilizing the synergistic effects of curcumin and the liver-targeting properties of GA.
Know more about this study https://www.nature.com/articles/srep44210
Singh H, Kim SJ, Kang DH, et al. Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity. ChemCommun (Camb). 2018;54(87):12353-12356.
Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity
Singh et al. explored the use of glycyrrhetinic acid (GA) as a hepatocyte-targeting unit for an anticancer drug delivery system, aiming to enhance the selectivity of drug delivery to liver cells. The study focused on improving the delivery of anticancer drugs specifically to hepatocytes, which are liver cells.
The research demonstrated that by incorporating GA as a targeting moiety, the drug delivery system exhibited enhanced selectivity for hepatocytes. This approach has the potential to improve the effectiveness of anticancer treatments while reducing off-target effects in non-liver tissues.
Know more about this study https://pubs.rsc.org/en/content/articlehtml/2018/cc/c8cc05175e
Cai Y, Xu Y, Chan HF, Fang X, He C, Chen M. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy. Mol Pharm. 2016;13(3):699-709.
Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy
Cai et al. conducted research on drug delivery carriers for hepatocellular carcinoma (HCC) therapy using glycyrrhetinic acid (GA) as a targeting ligand. The study aimed to develop an effective and liver-specific drug delivery system for treating HCC.
The research involved the design and synthesis of GA-conjugated drug carriers that could selectively target liver cells, particularly hepatocytes. These carriers were loaded with therapeutic agents for HCC treatment.
The results showed that the GA-mediated drug delivery carriers exhibited enhanced specificity for liver cells, which is crucial for targeting HCC. This approach has the potential to improve the therapeutic outcomes of HCC treatment by delivering drugs directly to the tumor site while minimizing systemic side effects.
Know more about this study https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.5b00677
Available from https://scialert.net/abstract/?doi=pjbs.2011.619.626.
Deng QP, Wang MJ, Zeng X, Chen GG, Huang RY. Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma. Cell PhysiolBiochem. 2017;41(4):1383-1392.
Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma
In a study conducted by Deng et al., the effects of glycyrrhizin (GA) were investigated in a mouse model of lung adenocarcinoma. The research aimed to explore the potential therapeutic benefits of GA in the context of lung cancer.
The study involved the use of a mouse model of lung adenocarcinoma induced by the carcinogen urethane. GA was administered to the mice to assess its impact on tumor growth and progression.
The findings indicated that GA treatment led to a significant reduction in tumor size and inhibited the proliferation of lung cancer cells. Moreover, GA appeared to modulate various signaling pathways associated with cancer progression.
Know more about this study https://karger.com/cpb/article/41/4/1383/73961
Haghshenas V, Fakhari S, Mirzaie S, et al. Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cells. Adv Pharm Bull. 2014;4(Suppl 1):437-41.
Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cells
In a study conducted by Haghshenas et al., the potential anti-cancer effects of Glycyrrhetinic Acid (GA) were investigated in ovarian cancer A2780 cells. The research aimed to determine whether GA could inhibit cell growth and induce apoptosis in these cancer cells.
The study involved treating A2780 ovarian cancer cells with GA and evaluating its impact on cell proliferation and apoptosis. The findings indicated that GA treatment led to a significant inhibition of cell growth and induced apoptosis in the cancer cells. This effect was associated with changes in cell morphology and DNA fragmentation, which are characteristic of apoptosis.
The results of this study suggest that Glycyrrhetinic Acid may have anti-cancer properties in the context of ovarian cancer by inhibiting cell growth and promoting apoptosis. Further research is needed to elucidate the underlying mechanisms and to explore its potential as a therapeutic agent for ovarian cancer treatment.
Know more about this study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213782/
Cao D, Wu Y, Jia Z, et al. 18β-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation regulated TLR2 signaling pathway. Carcinogenesis. 2018.
18β-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation-regulated TLR2 signaling pathway
In a study conducted by Cao et al., the potential anti-cancer effects of 18β-glycyrrhetinic acid (GA) were investigated in the context of gastric carcinogenesis. The research aimed to elucidate the molecular mechanisms by which GA exerts its anti-cancer properties and its impact on mitochondrial energy metabolism and the Toll-like receptor 2 (TLR2) signaling pathway.
The study involved the use of gastric cancer cell lines and in vivo models to assess the effects of GA on gastric carcinogenesis. The findings revealed that GA treatment inhibited mitochondrial energy metabolism in gastric cancer cells, leading to reduced cell proliferation and growth. Furthermore, GA was found to modulate the TLR2 signaling pathway through DNA methylation, resulting in the suppression of inflammation and cancer progression.
Know more about this study https://academic.oup.com/carcin/article-abstract/40/2/234/5144909
Hostetler BJ, Uchakina ON, Ban H, Mckallip RJ. Treatment of Hematological Malignancies with Glycyrrhizic Acid. Anticancer Res. 2017;37(3):997-1004.
Treatment of hematological malignancies with glycyrrhizic acid
The study conducted by Hostetler et al. investigated the potential use of glycyrrhizic acid (GA) in the treatment of hematological malignancies, which are cancers that affect the blood, bone marrow, and lymphatic system. The research aimed to assess the anti-cancer properties of GA in the context of hematological cancers.
In this study, various hematological cancer cell lines and animal models were utilized to evaluate the effects of GA treatment. The findings suggested that GA exhibited anti-cancer activity against hematological malignancies, leading to reduced cancer cell proliferation and increased apoptosis (programmed cell death) in cancer cells. It was also observed that GA modulated various signaling pathways involved in cancer progression.
Know more about this study https://ar.iiarjournals.org/content/37/3/997.short
Logemann W, Lauria F, Cudkowicz G, Franceschini J. Antileukæmic activity of glycyrrhetinic acid. Nature. 1960;187(4737):607–608.
Antileukaemic activity of glycyrrhetinic acid
The study conducted by Logemann, Lauria, Cudkowicz, and Franceschini in 1960 explored the potential antileukemic (anti-leukemia) activity of glycyrrhetinic acid. Leukemia is a type of cancer that affects the blood and bone marrow, characterized by the uncontrolled growth of abnormal white blood cells.
In this research, the scientists investigated the effects of glycyrrhetinic acid on leukemia cells, aiming to determine if it had any inhibitory or therapeutic properties against leukemia. The findings reported that glycyrrhetinic acid demonstrated antileukemic activity. Specifically, it appeared to inhibit the growth or proliferation of leukemia cells, which is a desirable effect in the context of cancer treatment.
Know more about this study https://www.nature.com/articles/187607a0
Hawthorne S, Gallagher S. Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells. J Pharm Pharmacol. 2008;60(5):661-6.
Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells
The study conducted by Hawthorne and Gallagher in 2008 investigated the effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen (PSA) secretion in LNCaP prostate cancer cells.
Prostate cancer is a type of cancer that develops in the prostate gland, a part of the male reproductive system. PSA is a protein produced by the prostate gland, and its levels are often elevated in individuals with prostate cancer.
In this research, the scientists aimed to understand how glycyrrhetinic acid, a compound found in licorice, and liquorice extract affect the behavior of prostate cancer cells. They specifically looked at cell proliferation, which is the process of cell growth and division, and PSA secretion, as elevated PSA levels are a marker of prostate cancer.
Know more about this study https://onlinelibrary.wiley.com/doi/abs/10.1211/jpp.60.5.0013
Thiugnanam S, Xu L, Ramaswamy K, Gnanasekar M. Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncology Reports. 2008;20(6):1387–1392.
Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP
In the study conducted by Thiugnanam et al. in 2008, the researchers investigated the potential anticancer effects of glycyrrhizin in prostate cancer cell lines DU-145 and LNCaP.
Prostate cancer is a common type of cancer that affects the prostate gland in men. Apoptosis is a programmed cell death process that plays a crucial role in controlling cell growth and preventing the development of cancer. Dysregulation of apoptosis can contribute to the progression of cancer.
In this research, the scientists aimed to determine whether glycyrrhizin, a natural compound found in licorice, could induce apoptosis in prostate cancer cells. They specifically studied two prostate cancer cell lines, DU-145 and LNCaP, which are commonly used in prostate cancer research.
The findings of the study demonstrated that glycyrrhizin had the ability to induce apoptosis in both DU-145 and LNCaP prostate cancer cell lines. This suggests that glycyrrhizin may have potential as a therapeutic agent in the treatment of prostate cancer by promoting programmed cell death in cancer cells.
Know more about this study https://www.spandidos-publications.com/10.3892/or_00000157
Huang RY, Chu YL, Huang QC, et al. 18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer. PLoS ONE. 2014;9(4):e93690.
18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer
In the study conducted by Huang et al. in 2014, the researchers investigated the potential anticancer effects of 18β-glycyrrhetinic acid (18β-GA) in non-small cell lung cancer (NSCLC).
Non-small cell lung cancer is a common type of lung cancer that accounts for the majority of lung cancer cases. It is known that abnormal cell proliferation plays a critical role in the development and progression of cancer.
Thromboxane synthase is an enzyme involved in the production of thromboxane A2, a molecule that promotes platelet aggregation and vasoconstriction. Thromboxane A2 has been associated with cancer cell proliferation and metastasis.
Know more about this study https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093690
Available from https://link.springer.com/article/10.1134/S0026893318020073.
Chang M, Wu M, Li H. Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice. Drug Deliv. 2018;25(1):1984-1995.
Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice
The study titled “Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice” by Chang, M., Wu, M., and Li, H. investigated the antitumor effects of glycyrrhetinic acid-modified curcumin-loaded cationic liposomes.
In this study, researchers developed a novel drug delivery system using cationic liposomes modified with glycyrrhetinic acid (GA) to encapsulate curcumin, a natural compound known for its potential anticancer properties. The goal was to enhance the targeted delivery of curcumin to tumor cells, improving its efficacy in treating cancer.
The research involved both in vitro experiments using cancer cell lines and in vivo experiments using mice with H22 tumors. The results indicated that the glycyrrhetinic acid-modified curcumin-loaded cationic liposomes exhibited significant antitumor activities. This suggests that the combination of glycyrrhetinic acid modification and liposomal delivery of curcumin could be a promising approach for cancer therapy.
Know more about this study https://www.tandfonline.com/doi/abs/10.1080/10717544.2018.1526227
Wang H, Fang ZZ, Meng R, et al. Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthylisothiocyanate-induced liver injury and bile acid cycle disruption. Toxicology. 2017;386:133-142.
Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption
The study conducted by Wang, H., Fang, Z.Z., Meng, R., and colleagues, investigated the potential protective effects of glycyrrhizin and glycyrrhetinic acid against liver injury induced by alpha-naphthylisothiocyanate (ANIT) and disruption of the bile acid cycle.
In this research, the authors used an ANIT-induced liver injury model to assess the impact of glycyrrhizin and glycyrrhetinic acid on liver health. ANIT is a chemical known to cause liver damage and disrupt the normal bile acid cycle.
The results of the study demonstrated that both glycyrrhizin and glycyrrhetinic acid had protective effects against ANIT-induced liver injury and helped mitigate the disruption of the bile acid cycle. These findings suggest that these compounds may have potential therapeutic benefits in the context of liver health and protection against liver injury.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0300483X1730152X
Chan HT, Chan C, Ho JW. Inhibition of glycyrrhizic acid on aflatoxin B1-induced cytotoxicity in hepatoma cells. Toxicology. 2003;188(2-3):211-7.
Inhibition of glycyrrhizic acid on aflatoxin B1-induced cytotoxicity in hepatoma cells
The study conducted by Chan, H.T., Chan, C., and Ho, J.W. investigated the inhibitory effects of glycyrrhizic acid on aflatoxin B1-induced cytotoxicity in hepatoma cells.
Aflatoxin B1 (AFB1) is a potent carcinogen produced by certain molds and is known to induce cytotoxicity and DNA damage, particularly in the liver.
In this research, the authors aimed to assess whether glycyrrhizic acid could protect hepatoma cells from the cytotoxic effects of AFB1. The results of the study demonstrated that glycyrrhizic acid had an inhibitory effect on AFB1-induced cytotoxicity in hepatoma cells. This suggests that glycyrrhizic acid may have potential protective properties against the harmful effects of AFB1 exposure.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0300483X03000878
Xiao Y, Xu J, Mao C, et al. 18Beta-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha. J Biol Chem. 2010;285(2):1128-37.
18Beta-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha
The study conducted by Xiao Y, Xu J, Mao C, et al. investigated the effects of 18Beta-glycyrrhetinic acid (18β-GA) on acute Propionibacterium acnes-induced liver injury and its potential mechanisms.
Propionibacterium acnes (P. acnes) is a bacterium associated with acne, but it can also cause liver injury under certain conditions.
In this research, the authors aimed to assess whether 18β-GA could ameliorate liver injury induced by P. acnes and explore the underlying mechanisms. The study found that 18β-GA treatment significantly reduced liver injury in the P. acnes-induced model. Additionally, it was observed that 18β-GA inhibited the production of macrophage inflammatory protein-1alpha (MIP-1α), a pro-inflammatory cytokine involved in liver injury.
Know more about this study https://www.jbc.org/article/S0021-9258(20)58869-8/abstract
Yang G, Wang L, Yu X, et al. Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats. Evid Based Complement Alternat Med. 2017;2017:3470320. doi:10.1155/2017/3470320.
Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats
The study conducted by Yang G, Wang L, Yu X, et al. aimed to investigate the protective effect of 18β-Glycyrrhetinic Acid (18β-GA) against hepatotoxicity induced by Triptolide, a natural compound known for its potential hepatotoxicity.
In this research, rats were administered with Triptolide to induce hepatotoxicity, and the protective effects of 18β-GA were evaluated. The study found that 18β-GA treatment significantly alleviated the hepatotoxicity induced by Triptolide. It improved liver function, reduced oxidative stress markers, and decreased the levels of inflammatory cytokines in the liver.
These results suggest that 18β-GA has a protective effect against Triptolide-induced hepatotoxicity, possibly through its antioxidant and anti-inflammatory properties.
Know more about this study https://www.hindawi.com/journals/ecam/2017/3470320/abs/
Li JY, Cao HY, Liu P, Cheng GH, Sun MY. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014:872139. doi:10.1155/2014/872139.
Glycyrrhizic acid in the treatment of liver diseases: literature review
The literature review by Li JY, Cao HY, Liu P, Cheng GH, Sun MY explores the therapeutic potential of Glycyrrhizic Acid (GA) in treating liver diseases. GA, a natural compound found in licorice root, has demonstrated anti-inflammatory and antiviral properties, making it a promising candidate for hepatitis treatment, including hepatitis B and C. Additionally, GA has shown potential in inhibiting liver fibrosis, protecting against drug-induced liver injury, and inhibiting the growth of liver cancer cells. The review delves into the mechanisms underlying GA’s hepatoprotective effects, such as its antioxidant and anti-inflammatory properties. While the findings are promising, further research and clinical trials are needed to establish its efficacy and safety in clinical practice.
Know more about this study https://www.hindawi.com/journals/bmri/2014/872139/abs/
Korenaga M, Hidaka I, Nishina S, et al. A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice. Liver Int. 2011;31(4):552-60.
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
In the study by Korenaga et al., a glycyrrhizin-containing preparation was investigated for its potential to reduce hepatic steatosis induced by hepatitis C virus (HCV) protein and iron in mice. Hepatic steatosis, characterized by the accumulation of fat in the liver, is a common consequence of chronic HCV infection. The researchers aimed to determine whether glycyrrhizin, a compound derived from licorice root known for its anti-inflammatory and hepatoprotective properties, could mitigate this condition. The results showed that the glycyrrhizin-containing preparation effectively reduced hepatic steatosis in mice exposed to both HCV protein and iron, suggesting its potential as a therapeutic approach to address liver complications associated with chronic HCV infection. This study highlights the importance of investigating natural compounds like glycyrrhizin for their potential in liver disease management.
Know more about this study https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1478-3231.2011.02469.x
Tang B, Qiao H, Meng F, Sun X. Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats. Brazilian Journal of Medical and Biological Research. 2007;40(12):1637–1646.
Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats
In the study conducted by Tang et al., the researchers explored the potential protective effects of glycyrrhizin in attenuating endotoxin-induced acute liver injury following partial hepatectomy in rats. Acute liver injury can be a serious complication following surgical procedures like hepatectomy. Endotoxins, often released from bacterial infections, can exacerbate liver damage. Glycyrrhizin, a natural compound found in licorice root, is known for its anti-inflammatory and hepatoprotective properties. The study aimed to investigate whether glycyrrhizin could mitigate liver injury in this context. The results demonstrated that glycyrrhizin treatment was effective in reducing the severity of liver injury induced by endotoxin following partial hepatectomy in rats. This suggests that glycyrrhizin may have potential therapeutic benefits in protecting the liver from acute injury associated with surgical procedures.
Know more about this study https://www.scielo.br/j/bjmbr/a/hJGWWF6VvMrFmg4D9krgNqR/?lang=en
Ogiku M, Kono H, Hara M, Tsuchiya M, Fujii H. Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by kupffer cells after ischemia-reperfusion in rats. Journal of Pharmacology and Experimental Therapeutics. 2011;339(1):93–98.
Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats
The study conducted by Ogiku et al. investigated the protective effects of glycyrrhizin against liver injury caused by ischemia-reperfusion in rats. Ischemia-reperfusion injury is a common complication that occurs when blood flow is temporarily restricted and then restored to an organ or tissue. This process can lead to inflammation and tissue damage. In this study, the researchers focused on the role of Kupffer cells, specialized liver macrophages, and their production of high-mobility group box 1 (HMGB1), a molecule associated with inflammation and tissue damage. The results showed that glycyrrhizin treatment effectively inhibited the production of HMGB1 by Kupffer cells, thereby reducing liver injury caused by ischemia-reperfusion. These findings suggest that glycyrrhizin may have a protective role in preventing liver damage under conditions of ischemia-reperfusion injury.
Know more about this study https://jpet.aspetjournals.org/content/339/1/93.short
Tu C-T, Li J, Wang F-P, Li L, Wang J-Y, Jiang W. Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway. International Immunopharmacology. 2012;14(4):410–421.
Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway
The study conducted by Tu et al. investigated the regulatory effects of glycyrrhizin on CD4+ T cell responses during liver fibrogenesis and the underlying molecular pathways involved. Liver fibrogenesis is a process characterized by the excessive accumulation of extracellular matrix proteins, and CD4+ T cells play a role in the immune response during this process. The researchers found that glycyrrhizin treatment had a regulatory effect on CD4+ T cell responses. It was shown to modulate the activity of several signaling pathways, including JNK, ERK, and PI3K/AKT, which are involved in immune responses and cell proliferation. These findings suggest that glycyrrhizin may have potential therapeutic effects in mitigating liver fibrogenesis by regulating CD4+ T cell responses through the modulation of these signaling pathways.
Know more about this study https://www.sciencedirect.com/science/article/pii/S156757691200255X
Zhao J, Wan X-Y, Luo M, Chen T-S, He P. Antifibrotic effects of glycyrrhizin and matrine in vitro and in vivo. Biomedicine and Preventive Nutrition. 2012;2(2):132–137.
Antifibrotic effects of glycyrrhizin and matrine in vitro and in vivo. Biomedicine and Preventive Nutrition
The study by Zhao et al. investigated the potential antifibrotic effects of glycyrrhizin and matrine both in vitro and in vivo. Liver fibrosis is a pathological condition characterized by excessive accumulation of extracellular matrix proteins in response to chronic liver injury. The researchers found that glycyrrhizin and matrine exhibited antifibrotic properties in both cell culture experiments (in vitro) and animal models (in vivo). These natural compounds were shown to inhibit the activation of hepatic stellate cells, which are key players in the development of liver fibrosis. Additionally, they reduced the production of pro-fibrotic factors and collagen deposition in the liver. This study suggests that glycyrrhizin and matrine may have therapeutic potential in the treatment of liver fibrosis by targeting key processes involved in fibrotic tissue formation.
Know more about this study https://www.sciencedirect.com/science/article/pii/S2210523912000049
Wan XY, Luo M, Li XD, He P. Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. ChemBiol Interact. 2009;181(1):15-9.
Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine
The research conducted by Wan et al. explored the hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. The study aimed to investigate the potential benefits of these natural compounds in protecting the liver from damage and preventing the development of hepatocellular carcinoma (liver cancer). The findings indicated that both glycyrrhizin and matrine exhibited hepatoprotective properties by reducing liver injury and inflammation. Additionally, they showed anti-hepatocarcinogenic effects by inhibiting the growth of liver cancer cells. These results suggest that glycyrrhizin and matrine may have therapeutic potential in liver-related diseases, including protecting the liver from damage and potentially preventing the progression of liver cancer.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0009279709001720
Tsukasa Ishida, Yoshiyuki Mizushina, SaoriYagi, et al., “Inhibitory Effects of Glycyrrhetinic Acid on DNA Polymerase and Inflammatory Activities,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 650514, 9 pages, 2012. https://doi.org/10.1155/2012/650514.
Inhibitory effects of glycyrrhetinic acid on DNA polymerase and inflammatory activities
In their study, Ishida et al. investigated the inhibitory effects of glycyrrhetinic acid on DNA polymerase and inflammatory activities. The research aimed to understand how glycyrrhetinic acid, a natural compound found in licorice root, affects DNA polymerase, an enzyme involved in DNA replication, and its potential anti-inflammatory properties. The findings revealed that glycyrrhetinic acid exhibited inhibitory effects on DNA polymerase activity, suggesting its potential role in regulating DNA replication processes. Additionally, the study indicated that glycyrrhetinic acid displayed anti-inflammatory properties, which could have implications for its use in managing inflammatory conditions. This research contributes to the understanding of the biological activities of glycyrrhetinic acid and its potential therapeutic applications.
Know more about this study https://www.hindawi.com/journals/ecam/2012/650514/
Mencucci R, Favuzza E, Menchini U. Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy in the treatment of moderate to severe blepharitis. ClinOphthalmol. 2013;7:1403-10.
Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy in the treatment of moderate to severe blepharitis
Mencucci et al. conducted a study to assess the tolerability and efficacy of an ophthalmic solution containing 5% glycyrrhizin and copolymer PEG/PPG in the treatment of moderate to severe blepharitis. The research involved healthy volunteers and aimed to evaluate the safety and effectiveness of this ophthalmic solution in managing the eye condition. The results indicated that the solution was well-tolerated by the participants, suggesting its safety for ophthalmic use. Furthermore, the study demonstrated its efficacy in treating moderate to severe blepharitis, highlighting its potential as a therapeutic option for individuals with this eye condition. This research contributes valuable insights into the use of glycyrrhizin-containing ophthalmic solutions for ocular health.
Know more about this study https://www.tandfonline.com/doi/abs/10.2147/OPTH.S47657
Gujral ML, Sareen K, Phukan DP, Amma MK. Antiarthritic activity of glycyrrhizin in adrenalectomised rats. Indian J Med Sci. 1961;15:624-9.
Antiarthritic activity of glycyrrhizin in adrenalectomised rats
The study conducted by Gujral et al. in 1961 investigated the antiarthritic activity of glycyrrhizin in adrenalectomized rats. Adrenalectomy involves the removal of the adrenal glands, which are responsible for producing various hormones, including glucocorticoids that play a role in inflammation and immune responses. The research aimed to assess whether glycyrrhizin, a compound found in licorice root, had any beneficial effects on arthritis in rats that had undergone adrenalectomy. The results of this study may have provided insights into the potential anti-inflammatory or immunomodulatory properties of glycyrrhizin in the context of arthritis.
Know more about this study https://europepmc.org/article/med/13709694
Zhang H, Song Y, Zhang Z. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice. Am J Med Sci. 2012;344(3):206-10.
Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice
In the study conducted by Zhang et al. in 2012, the researchers investigated the effects of glycyrrhizin administration on coxsackievirus B3-induced myocarditis in mice. Myocarditis is an inflammation of the heart muscle, often caused by viral infections such as coxsackievirus B3. The study aimed to determine whether glycyrrhizin, a compound derived from licorice root, could alleviate the symptoms and pathology associated with viral-induced myocarditis. The findings of this research may have provided valuable insights into the potential therapeutic benefits of glycyrrhizin in mitigating viral myocarditis in mice, which could have implications for the treatment of similar conditions in humans.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0002962915308557
Park HY, Park SH, Yoon HK, Han MJ, Kim DH. Anti-allergic activity of 18beta-glycyrrhetinic acid-3-O-beta-D-glucuronide. Arch Pharm Res. 2004;27(1):57-60.
Anti-allergic activity of 18beta-glycyrrhetinic acid-3-O-beta-D-glucuronide
The study conducted by Park et al. in 2004 investigated the anti-allergic activity of 18β-glycyrrhetinic acid-3-O-beta-D-glucuronide. Allergies are immune responses to typically harmless substances, and this study aimed to assess the potential of a specific compound derived from glycyrrhetinic acid in reducing allergic reactions. The findings may have provided insights into the development of anti-allergic agents and their mechanisms of action, which could be beneficial for individuals with allergic conditions.
Know more about this study https://link.springer.com/article/10.1007/BF02980047
Genovese T, Menegazzi M, Mazzon E, et al. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock. 2009;31(4):367-75.
Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice
The study conducted by Genovese et al. in 2009 investigated the effects of glycyrrhizin in reducing secondary inflammatory processes after spinal cord compression injury in mice. Spinal cord injuries can lead to inflammation and tissue damage beyond the initial injury site, causing further complications. Glycyrrhizin, a compound derived from licorice root, was studied for its potential to mitigate these secondary inflammatory responses. The findings suggested that glycyrrhizin might have therapeutic potential in reducing inflammation associated with spinal cord injuries, which could be a promising avenue for future research in spinal cord injury treatment.
Know more about this study https://journals.lww.com/shockjournal/Fulltext/2009/04000/Cerebrospinal_Fluid_Concentrations_of.7.aspx
Ni B, Cao Z, Liu Y. Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury. Int J Neurosci. 2013;123(11):745-51.
Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury
The study conducted by Ni et al. in 2013 investigated the protective effects of glycyrrhizin in the context of spinal cord ischemia-reperfusion injury. This type of injury occurs when blood flow to the spinal cord is temporarily interrupted and then restored, leading to inflammation and tissue damage. The study aimed to assess whether glycyrrhizin could reduce inflammation and protect the spinal cord in this scenario. The results suggested that glycyrrhizin has potential neuroprotective properties and may help mitigate inflammation associated with spinal cord ischemia-reperfusion injury, highlighting its potential as a therapeutic agent for such conditions.
Know more about this study https://www.tandfonline.com/doi/abs/10.3109/00207454.2013.796551
Li XL, Zhou AG, Zhang L, Chen WJ. Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice. Int J Mol Sci. 2011;12(2):905-16.
Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice
The research conducted by Li et al. in 2011 investigated the effects of glycyrrhizin on antioxidant status and immune activity in mice with allergic rhinitis. Allergic rhinitis is an inflammatory condition triggered by allergens, and oxidative stress and immune dysfunction are often associated with it. The study aimed to determine whether glycyrrhizin, a compound derived from licorice, could modulate antioxidant defenses and immune responses in this context. The findings suggested that glycyrrhizin may have a positive impact by enhancing antioxidant status and immune activity, potentially offering relief from the symptoms of allergic rhinitis. This research highlights the potential therapeutic benefits of glycyrrhizin in managing allergic conditions.
Know more about this study https://www.mdpi.com/1422-0067/12/2/905
Song JH, Lee JW, Shim B, et al. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules. 2013;18(12):15788-803.
Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice
In their study published in 2013, Song et al. explored the potential neuroprotective effects of glycyrrhizin in mice treated with systemic lipopolysaccharide (LPS), which is known to induce neuroinflammation and memory deficits. The researchers aimed to investigate whether glycyrrhizin, a compound found in licorice, could alleviate these negative effects. The results of the study indicated that glycyrrhizin treatment had a beneficial impact by reducing neuroinflammation and improving memory deficits caused by LPS administration. This research suggests that glycyrrhizin may have a neuroprotective role and could be further explored as a potential therapeutic agent for conditions associated with neuroinflammation and cognitive impairments.
Know more about this study https://www.mdpi.com/1420-3049/18/12/15788
Ram A, Mabalirajan U, Das M, et al. Glycyrrhizin alleviates experimental allergic asthma in mice. IntImmunopharmacol. 2006;6(9):1468-77.
Glycyrrhizin alleviates experimental allergic asthma in mice
In a study published in 2006, Ram et al. investigated the potential therapeutic effects of glycyrrhizin in an experimental allergic asthma model in mice. Allergic asthma is characterized by airway inflammation and hyperresponsiveness. The researchers aimed to determine whether glycyrrhizin, a compound found in licorice root, could alleviate the symptoms of allergic asthma. The results of the study demonstrated that glycyrrhizin treatment reduced airway inflammation, airway hyperresponsiveness, and the production of pro-inflammatory cytokines in the mice with allergic asthma. These findings suggest that glycyrrhizin may have anti-inflammatory and immunomodulatory properties, making it a potential candidate for the treatment of allergic asthma.
Know more about this study https://www.sciencedirect.com/science/article/pii/S1567576906001512
Hocaoglu AB, Karaman O, Erge DO, et al. Glycyrrhizin and long-term histopathologic changes in a murine model of asthma. CurrTher Res Clin Exp. 2011;72(6):250-61.
Glycyrrhizin and long-term histopathologic changes in a murine model of asthma
In a study published in 2011, Hocaoglu et al. investigated the effects of glycyrrhizin in a murine model of asthma, focusing on long-term histopathologic changes. Asthma is a chronic inflammatory respiratory condition, and this study aimed to assess whether glycyrrhizin, a compound found in licorice root, could have lasting effects on lung tissue in an experimental asthma model. The researchers found that glycyrrhizin treatment reduced airway inflammation, goblet cell hyperplasia, and collagen deposition in the lungs of asthmatic mice. These findings suggest that glycyrrhizin may have beneficial effects not only in alleviating acute asthma symptoms but also in preventing long-term histopathologic changes associated with chronic asthma. This study highlights the potential of glycyrrhizin as a therapeutic agent for asthma management.
Know more about this study https://www.sciencedirect.com/science/article/pii/S0011393X11001500
Lee Y, Jeong S, Kim W, et al. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis. Dig Dis Sci. 2013;58(5):1226-34.
Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis
In a study published in 2013 by Lee et al., the researchers investigated the potential therapeutic benefits of glycyrrhizin in combination with a colon-specific methylprednisolone prodrug for the treatment of experimental colitis. Colitis is characterized by inflammation of the colon, and this study aimed to assess whether glycyrrhizin could enhance the effectiveness of the prodrug in treating colitis. The results demonstrated that the combination of glycyrrhizin and the prodrug led to an enhanced therapeutic activity against colitis in experimental models. This suggests that glycyrrhizin may have a synergistic effect with the prodrug, making it a potential candidate for improving the treatment of colitis. The study highlights the potential of glycyrrhizin in combination therapies for inflammatory bowel diseases like colitis.
Know more about this study https://link.springer.com/article/10.1007/s10620-012-2495-7
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old
Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer
I am now in my mid-sixties and feel better than I did in my 20’s. Many people have commented that I actually look 20 years younger since I started the program at Genemedics.
Calling Dr. George has proven to be one of the best decisions I have made in my life. Doctors and society convince us that developing various health issues and negative sy...
Pamela Hill ,66 yrs old
Call 800-277-4041 for a Free Consultation
Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.
© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.
STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!
Call 800-277-4041 for a Free Consultation
What to expect during your consultation: